Legal claims defining the scope of protection, as filed with the USPTO.
1. A glucose monitoring system, comprising: a glucose sensor including a first portion configured to be positioned above a skin layer of the user, and a second portion configured to be implanted transcutaneously below the skin layer of the user into a subcutaneous space and in contact with an interstitial fluid of the user and having a working electrode, and a reference electrode, wherein the glucose sensor is configured to generate data signals associated with a glucose level of the interstitial fluid; one or more processors; and one or more memories storing a sensor code from manufacturing, wherein the memories are operatively coupled to the one or more processors for storing instructions which, when executed by the one or more processors, cause the one or more processors to: retrieve a sensitivity and a predefined sensitivity range from the sensor code from manufacturing; receive an unscheduled manual user calibration; determine a composite sensitivity using a time based function based on the sensitivity, the predefined sensitivity range, and the unscheduled manual user calibration; and determine a glucose level of the user based on the composite sensitivity and the data signals generated by the glucose sensor.
2. The glucose monitoring system of claim 1, wherein the unscheduled manual user calibration comprises causing a user input interface to be provided for display; and receiving a current blood glucose value from the user input interface.
3. The glucose monitoring system of claim 1, wherein the one or more processors and one or more memories are disposed within a transmitter unit.
4. The glucose monitoring system of claim 3, wherein the transmitter unit further comprises a first temperature sensor.
5. The glucose monitoring system of claim 4, wherein the instructions further cause the glucose level of the user to be based on a temperature reading from the first temperature sensor.
6. The glucose monitoring system of claim 5, wherein the transmitter unit further comprises a second temperature sensor.
7. The glucose monitoring system of claim 6, wherein the first temperature sensor is located at a first location within the transmitter unit and the second temperature sensor is located at a second location within the transmitter unit, wherein the first location is different than the second location.
8. The glucose monitoring system of claim 1, wherein the instructions further perform an associate routine.
9. The glucose monitoring system of claim 8, wherein the associate routine includes a data quality check.
10. The glucose monitoring system of claim 8, wherein the associate routine includes a glucose rate of change verification.
11. The glucose monitoring system of claim 8, wherein the associate routine includes digital filtering of the data signals.
Unknown
June 10, 2025
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.